hotspot -WSS

hotspot

author：fashion 2025-10-01 21:36:00 - browse：7462

AI skin cancer detector, dermasensor. -- health tech coverage from STAT — Around 5 million skin cancers are diagnosed each year in the United States. Skin cancer is common, but it’s also not that deadly when caught early. Courtesy DermaSensor

The Food and Drug Administration cleared an AI-powered device for detecting skin cancer on Wednesday, giving primary care physicians a new way to evaluate troubling skin spots.

Around 5 million skin cancers are diagnosed each year in the United States. Skin cancer is common, but most types are not that deadly when caught early.

The device, developed by a small company called DermaSensor, is handheld and uses light to examine suspicious moles on a cellular level. It will be marketed specifically for primary care physicians to use in routine check-ups in patients aged 40 and above.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： ALS advocates say criticism of new drugs misses bigger picture

WSS

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

Covid hospitalizations on the rise, Humana says

How to protect patients from sexual assault

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

The dental labor crisis is a moment of opportunity

Gilead might be held responsible for not developing a drug

knowledge

hotspot

hotspot

Drug repurposing or repositioning? The language matters

Illumina names Agilent executive as new CEO

In age of alternative facts, a scholarly course on calling out crap

The dental labor crisis is a moment of opportunity

Peter Hotez and the public health issue of online harassment

Biogen Alzheimer’s drug launch off to slow start

Heart attack and stroke risk calculators need revising

What should King Charles tell the public about his cancer?

Medical leaders decry Supreme Court decision on affirmative action

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

leisure time

Industry veterans launch new biotech VC with $310M

A new House health package & hospitals’ new site

What drug price negotiations mean for Medicare Part D

What American doctors can learn from their Israeli counterparts

How digital tools helped lower hypertension in marginalized patients

How to fix cancer clinical trials' diversity problem

hotspot

focus

knowledge

hotspot